文献速递免疫规划传染病防控与疫情报告

2010-2016年波兰B群脑膜炎奈瑟菌遗传变异分析及4CMenB疫苗组分基因特征

Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes.
PubMed 文献 · Vaccine · 2020-01-21

研究对2010-2016年波兰662株侵袭性B群脑膜炎奈瑟菌进行MLST分型及4CMenB疫苗抗原编码基因测序,发现CC32、CC41/44和CC18为优势克隆群,分别占31.9%、16.5%和12.7%;菌株高度多样,exMATS和gMATS估计的4CMenB疫苗覆盖率分别为83.3%和86.6%。

要点

  • 662株B群脑膜炎奈瑟菌中CC32、CC41/44和CC18最常见,分别占31.9%、16.5%和12.7%。
  • 疫苗变异体VR2:4检出率7.3%,fHbp亚变异体1.1占24.2%,NHBA肽3占22.4%。
  • exMATS和gMATS估计4CMenB覆盖率分别为83.3%和86.6%,39.7%菌株至少携带一种疫苗变异体。

核心结论

  • 2010-2016年波兰B群脑膜炎奈瑟菌在MLST及4CMenB疫苗抗原编码基因等位基因上高度多样,克隆复合体与所检蛋白变异体/BAST型别间存在一定关联,估计4CMenB疫苗覆盖率较高。

研究设计与样本

  • 研究纳入2010-2016年波兰侵袭性B群脑膜炎奈瑟菌分离株662株,采用MLST分型及4CMenB疫苗抗原编码基因测序,并采用exMATS(外推2010-2011年波兰脑膜炎奈瑟菌MATS结果)和gMATS(结合基因分型与MATS结果)两种方法估计疫苗覆盖率。

主要发现

  • 662株中检出20个克隆复合体(CC),最常见为CC32(31.9%)、CC41/44(16.5%)和CC18(12.7%)。
  • PorA可变区VR1/VR2共有111种组合,以P1.7,16(15.0%)和P1.22,14(13.6%)为主;疫苗变异体VR2:4检出率为7.3%,主要见于CC41/44及未定型CC。
  • fHbp基因检出85个等位基因编码74种肽亚变异体,疫苗组分亚变异体1.1占24.2%,主要见于CC32;nhba基因检出102个等位基因编码87种肽,肽3最常见(22.4%),疫苗肽2检出率9.8%,主要见于CC41/44。
  • nadA基因检出率34.0%,最常见为肽1(NadA-1变异体,71.6%),几乎仅见于CC32;疫苗肽8(NadA-2/3变异体)仅检出1次;共获得292个完整BAST型别。
  • 39.7%菌株至少携带一种4CMenB疫苗变异体,exMATS和gMATS估计的疫苗覆盖率分别为83.3%和86.6%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neisseria meningitidis serogroup B (MenB) has recently become the major cause of invasive meningococcal disease in Poland. Therefore, the purpose of this study was to characterize MenB isolates, responsible for invasive meningococcal disease in 2010-2016, by MLST and sequencing of genes encoding proteins used as 4CMenB vaccine antigens. Two methods of coverage estimation were performed: extrapolation of MATS results of Polish meningococci 2010-2011 (exMATS) and gMATS, which combines genotyping and MATS results. Among 662 isolates 20 clonal complexes (CC) were detected, of which the most frequent were CC32, CC41/44 and CC18, accounting for 31.9%, 16.5% and 12.7%, respectively. A total of 111 combinations of PorA variable regions (VR1/VR2) were found, with P1.7,16 (15.0%) and P1.22,14 (13.6%) being prevalent. Vaccine variant VR2:4 was detected in 7.3% of isolates, mainly representing CC41/44 and non-assigned CC. Eighty five fHbp alleles encoding 74 peptide subvariants were revealed. Subvariant 1.1, a component of 4CMenB, was prevalent (24.2%) and found generally in CC32. Typing of the nhba gene revealed 102 alleles encoding 87 peptides. The most frequent was peptide 3 (22.4%), whereas vaccine peptide 2 was detected in 9.8%, mostly among CC41/44. The nadA gene was detected in 34.0% of isolates and the most prevalent was peptide 1 (variant NadA-1; 71.6%), found almost exclusively in CC32 meningococci. Vaccine peptide 8 (variant NadA-2/3) was identified once. Consequently, 292 completed BAST profiles were revealed. Regarding vaccine coverage, 39.7% of isolates had at least one 4CMenB vaccine variant, but according to exMATS and gMATS the coverage was 83.3% and 86.6%, respectively. In conclusion, Polish MenB (2010-2016) was highly diverse according to MLST and gene alleles encoding 4CMenB vaccine antigens. Some correlations between clonal complexes and variants of examined proteins/BAST profiles were revealed and a high coverage of 4CMenB vaccine was estimated.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Waśko I, Gołębiewska A, Kiedrowska M, et al. Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes. Vaccine. 2020. PMID: 31980191. doi:10.1016/j.vaccine.2020.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。